Investment analysts at StockNews.com began coverage on shares of Oragenics (NYSE:OGEN – Get Free Report) in a research report issued on Sunday. The brokerage set a “sell” rating on the stock.

Here is how the Barron’s Roundtable members’ picks performed. Find investment ideas for your portfolio with the latest stock picks from Barron’s below. These picks are the product of the ...